|

Trilaciclib Injection [Cosela] Clinical Trials

2 actively recruiting trials

Also known as: CDK 4/6 inhibitor, G1T28

Pipeline

Phase 2: 2

Top Sponsors

  • The First Affiliated Hospital with Nanjing Medical University1
  • Fudan University1

Indications

  • Cancer2
  • Myelosuppression1
  • Ewing Sarcoma1
  • Esophageal Cancer1

Other2 trials

A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib
Phase 2
Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.